Sunitinib in malignant melanoma: a treatment option only for KIT-mutated patients?

Daniele Santini, Bruno Vincenzi, Olga Venditti, Emanuela Dell'Aquila, Anna Maria Frezza, Marianna Silletta, Francesco Maria Guida, Rosario Francesco Grasso, Nicola Silvestris, Gaetano Lanzetta, Giuseppe Tonini

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Sunitinib in malignant melanoma: a treatment option only for KIT-mutated patients?'. Together they form a unique fingerprint.

Medicine & Life Sciences